NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer

被引：2

作者：

Casella, R ^{[1
]}

Lehmann, K ^{[1
]}

Gasser, TC ^{[1
]}

机构：

[1] Univ Basel Hosp, Urol Clin, CH-4031 Basel, Switzerland

来源：

JOURNAL OF UROLOGY | 1999年 / 162卷 / 02期

关键词：

D O I：

10.1016/S0022-5347(05)68609-0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：500 / 501

页数：2

共 4 条

[1] Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer [J].

Landman, J ;

Chang, Y ;

Kavaler, E ;

Droller, MJ ;

Liu, BCS .

UROLOGY, 1998, 52 (03) :398-402

[2] Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder [J].

Stampfer, DS ;

Carpinito, GA ;

Rodriguez-Villanueva, J ;

Willsey, LW ;

Dinney, CP ;

Grossman, HB ;

Fritsche, HA ;

McDougal, WS .

JOURNAL OF UROLOGY, 1998, 159 (02) :394-398

[3] Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? [J].

Wiener, HG ;

Mian, C ;

Haitel, A ;

Pycha, A ;

Schatzl, G ;

Marberger, M .

JOURNAL OF UROLOGY, 1998, 159 (06) :1876-1880

[4] NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer [J].

Zippe, C ;

Pandrangi, L ;

Agarwal, A .

JOURNAL OF UROLOGY, 1999, 161 (01) :62-65

← 1 →